Diabetes Obes Metab (2020) 22:44251
Switching to the oral small molecule glucagon-like peptide-1 (GLP-1) orforglipron after taking injectable GLP-1s helped patients maintain mostbut not allof their weight loss, according to a clinical trial led by Weill Cornell Medicine and NewYork-Presbyterian investigators
10.1142/s0192415x20500482 50 IqbalM
Current pharmacological strategies for UC primarily include 5-aminosalicylic acid (5-ASA), glucocorticoids, thiopurines, biological medications, and anti-cytokine therapies (Tsujii et al., 2022)
In this respect, more research efforts are essential and needed to minimize the risk of pulmonary aspiration and minimize anesthesia risk during sedated medical procedures in patients on GLP-1 RAs
The medication itself may be part of this strategy a pharmaceutical tool that allows them to pursue health goals without fully suppressing their appetite for consumption, novelty, and indulgence